Comparison of the pharmacokinetics and clinical efficacy of new extended-release formulations of methylphenidate

R Maldonado - Expert Opinion on Drug Metabolism & Toxicology, 2013 - Taylor & Francis
Introduction: Attention-deficit hyperactivity disorder (ADHD) is a common neurobehavioral
disorder of which the main features are inattention, hyperactivity and impulsivity …

Comparison of the pharmacokinetics and clinical efficacy of new extended-release formulations of methylphenidate

R Maldonado - Expert opinion on drug metabolism & …, 2013 - pubmed.ncbi.nlm.nih.gov
Introduction Attention-deficit hyperactivity disorder (ADHD) is a common neurobehavioral
disorder of which the main features are inattention, hyperactivity and impulsivity …

Comparison of the pharmacokinetics and clinical efficacy of new extended-release formulations of methylphenidate.

R Maldonado - Expert Opinion on Drug Metabolism & Toxicology, 2013 - europepmc.org
Attention-deficit hyperactivity disorder (ADHD) is a common neurobehavioral disorder of
which the main features are inattention, hyperactivity and impulsivity. Methylphenidate …